Yüklüyor......
EXTH-19. COMBINATION OF IN VITRO TUMOR TREATING FIELDS AND TEMOZOLOMIDE DECREASE PROLIFERATION IN PATIENT-DERIVED GLIOBLASTOMA CELL LINES
BACKGROUND: Tumor treating fields (TTFields) are FDA-approved for treatment of newly-diagnosed and recurrent glioblastoma. Adding TTFields therapy to standard-of-care temozolomide (TMZ) extended progression-free survival and overall survival in newly-diagnosed glioblastoma patients. In this study, c...
Kaydedildi:
| Yayımlandı: | Neuro Oncol |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5692458/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.314 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|